Frederic Lavie

11PUBLICATIONS
48CO-AUTHORS
Gene and molecular therapyRheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)PharmacogenomicsAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 23, 2026
Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study.

Laure Gossec, Xenofon Baraliakos, James Galloway

|Jul 21, 2025
Guselkumab Efficacy in Biologic-Naïve Participants with Psoriatic Arthritis and Severe Disease Activity: Post Hoc Analysis of a Phase 3 Study.

Christopher T Ritchlin, Ennio Lubrano, Maria Sole Chimenti

|Dec 13, 2024
Sustained response to guselkumab regardless of baseline characteristics in patients with active psoriatic arthritis and inadequate response to TNF inhibitors: results from the phase 3b COSMOS clinical trial.

Iain B McInnes, Philipp Sewerin, Mohamed Sharaf

|Nov 15, 2024
Patient Profiles in Randomized Controlled Trials Versus a Real-World Study in Psoriatic Arthritis: Scoping Review and Metaanalysis.

Gelsomina Alle, Clementina Lopez-Medina, Stefan Siebert

|Oct 22, 2024
Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS.

Laure Gossec, Xenofon Baraliakos, Daniel Aletaha

|Sep 25, 2024
Guselkumab in Biologic-Naïve Patients with Active Psoriatic Arthritis in Russia: A Post Hoc Analysis of the DISCOVER-1 and -2 Randomized Clinical Trials.

Philip Mease, Tatiana Korotaeva, Pavel Shesternya

Pageof 2

Frequent Collaborators

6 joint publications

Mohamed Sharaf

5 joint publications

Philip Mease

5 joint publications

Soumya D Chakravarty

5 joint publications

May Shawi